Applied DNA to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on December 14, 2022
13 December 2022 - 2:00AM
Business Wire
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a
leader in PCR-based DNA technologies, today announced that it plans
to release its fiscal 2022 fourth quarter and year-end financial
results after the market close on Wednesday, December 14, 2022.
The Company’s management will host a conference call with
investors and covering analysts starting at 4:30 pm ET that same
day. On the call, Chief Financial Officer Beth Jantzen and
President and CEO Dr. James A. Hayward will discuss the Company’s
quarterly financial performance and recent accomplishments,
followed by a question-and-answer session.
To access the conference call:
- U.S. callers should dial 1-844-887-9402, and international
callers should dial +1-412-317-6798 approximately five minutes
before the call begins.
- Participants should ask to be connected to the Applied DNA
Financial Results conference call.
You can listen to the call and view the accompanying exhibits on
Applied DNA’s investor relations website at
https://investors.adnas.com/news-events/company-events/ at the
scheduled time. A webcast replay of the call will also be available
on the investor relations website approximately one hour after the
end of the call.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing
technologies to produce and detect deoxyribonucleic acid ("DNA").
Using the polymerase chain reaction ("PCR") to enable both the
production and detection of DNA, we operate in three primary
business markets: (i) the manufacture of DNA for use in nucleic
acid-based therapeutics; (ii) the detection of DNA in molecular
diagnostics testing services; and (iii) the manufacture and
detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
The Company's common stock is listed on NASDAQ under the ticker
symbol 'APDN,' and its publicly traded warrants are listed on OTC
under the ticker symbol 'APPDW.'
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221212005542/en/
Investor Relations: Sanjay M. Hurry, 917-733-5573,
sanjay.hurry@adnas.com Web: www.adnas.com Twitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024